Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs?
Jacob
Martha
M
EngenderHealth, New York, NY 10001, USA.
Bradley
Janet
J
Barone
Mark A
MA
D003906:Developing Countries; D005260:Female; D005544:Forecasting; D006801:Humans; D017589:Immunization Programs / Q000639:trends*; D008507:Medically Underserved Area; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology; D014765:Viral Vaccines / Q000627:therapeutic use*; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control* / Q000821:virology
D053918:Papillomavirus Vaccines; D014765:Viral Vaccines